Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2009

Jun 12, 2009

30786_dirs_2009-06-12_a073320e-1069-4573-aa17-6123b0187e85.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2009-06-10

Reporting Person: SCHWARTZ NORMAN D (Director, CEO, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-06-10 Restricted Stock Units $0 A 12000 Acquired Bio-Rad B Common Stock (12000) Direct
2009-06-10 Non-Qualified Stock Option (right to buy) $75.38 A 37000 Acquired 2019-06-10 Bio-Rad B Common Stock (37000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 262120 Direct
Bio-Rad B Common Stock 76974 Direct
Bio-Rad B Common Stock 4060054 Indirect
Bio-Rad B Common Stock 11600 Indirect

Footnotes

F1: The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F2: The reporting person disclaims beneficial ownership of these shares.

F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class B common stock.

F4: The restricted stock units vest over five years at 20% per year on the yearly anniversary date of the grant.

F5: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.